Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Favaretto · SciRah

Researcher profile · Semantic Scholar

A. Favaretto

Share profile

A. Favaretto — researcher profile on SciRah

h-index: 29
Works: 148
Citations: 6,090

Most-cited papers

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.
M. di Maio, C. Gallo, N. Leighl, M. Piccirillo +16 more
2015Journal of Clinical Oncology450 citations Open access
Semantic Scholar
Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
G. Scagliotti, J. von Pawel, S. Novello, R. Ramlau +15 more
2015Journal of Clinical Oncology264 citations Open access
Semantic Scholar
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors
I. Petrini, P. Meltzer, In-Kyu Kim, M. Lucchi +18 more
2014Nature Genetics249 citations Open access
Semantic Scholar
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial.
C. Gridelli, F. Ciardiello, C. Gallo, R. Feld +24 more
2012Journal of Clinical Oncology239 citations Open access
Semantic Scholar
Nondisruptive p53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non–Small Cell Lung Cancer
M. Molina-Vila, J. Bertran-Alamillo, A. Gascó, C. Mayo-de-las-Casas +12 more
2014Clinical Cancer Research151 citations Open access
Semantic Scholar
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.
P. Zucali, T. De Pas, G. Palmieri, A. Favaretto +20 more
2014Journal of Clinical Oncology143 citations
Semantic Scholar
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial.
P. Ellis, F. Shepherd, M. Millward, F. Perrone +20 more
2014The Lancet Oncology127 citations
Semantic Scholar
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes.
L. Bonanno, A. Pavan, M. Dieci, E. Di Liso +11 more
2018European Journal of Cancer108 citations Open access
Semantic Scholar
Platinum drugs and DNA repair mechanisms in lung cancer.
L. Bonanno, A. Favaretto, R. Rosell
2014Anticancer Research73 citations
Semantic Scholar
A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-line Treatment for EGFR-mutation Positive NSCLC Patients.
G. Scagliotti, D. Moro-Sibilot, J. Kollmeier, A. Favaretto +15 more
2019Journal of Thoracic Oncology70 citations Open access
Semantic Scholar
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial.
V. Gregorc, R. Gaafar, A. Favaretto, F. Grossi +14 more
2018The Lancet Oncology66 citations Open access
Semantic Scholar
Effects of sulfonylureas on tumor growth: a review of the literature.
G. Pasello, L. Urso, P. Conte, A. Favaretto
2013The Oncologist60 citations Open access
Semantic Scholar
Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment.
L. Urso, F. Calabrese, A. Favaretto, P. Conte +1 more
2016Critical reviews in oncology/hematology50 citations
Semantic Scholar
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
A. Bearz, R. Talamini, G. Rossoni, A. Santo +9 more
2012BMC Research Notes49 citations Open access
Semantic Scholar
LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab
L. Bonanno, A. De Paoli, E. Zulato, G. Esposito +16 more
2017Clinical Cancer Research47 citations
Semantic Scholar
Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma.
L. Bonanno, M. Schiavon, G. Nardo, R. Bertorelle +6 more
2010Anticancer Research47 citations
Semantic Scholar
Efficacy Analysis for Molecular Subgroups in MARQUEE: a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial of Tivantinib (ARQ 197) Plus Erlotinib versus Placebo plus Erlotinib in Previously Treated Patients with Locally Advanced or Metastatic, Non-squamous, Non-small Cell Lung Cancer (NSCLC
J. von Pawel, G. Scagliotti, S. Novello, R. Ramlau +15 more
201430 citations
Semantic Scholar
Phase II Study of Afatinib, an Irreversible ErbB Family Blocker, in EGFR FISH-Positive Non–Small-Cell Lung Cancer
F. Cappuzzo, G. Finocchiaro, F. Grossi, P. Bidoli +7 more
2015Journal of Thoracic Oncology29 citations Open access
Semantic Scholar
Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors and new therapeutic perspectives in non small cell lung cancer.
L. Bonanno, A. Jirillo, A. Favaretto
2011Current Drug Targets29 citations
Semantic Scholar
Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients
C. Gridelli, S. Novello, N. Zilembo, A. Luciani +16 more
2014Journal of Thoracic Oncology28 citations Open access
Semantic Scholar
Multidisciplinary approach for advanced stage thymic tumors: long-term outcome.
F. Rea, G. Marulli, F. Di Chiara, M. Schiavon +4 more
2011Lung Cancer28 citations
Semantic Scholar
Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel.
F. de Marinis, E. Bria, P. Baas, M. Tiseo +3 more
2015Clinical Lung Cancer27 citations
Semantic Scholar
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer
L. Bonanno, C. Costa, M. Majem, J. Sánchez +10 more
2016BMC Cancer26 citations Open access
Semantic Scholar
An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.
G. Pasello, G. Ceresoli, A. Favaretto
2013Cancer Treatment Reviews26 citations
Semantic Scholar
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy
L. Bonanno, C. Costa, M. Majem, J. Sánchez +9 more
2013OncoTarget26 citations Open access
Semantic Scholar
Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.
C. Gridelli, A. Rossi, M. di Maio, S. Leo +13 more
2014Clinical Lung Cancer25 citations
Semantic Scholar
Results of surgical resection after induction chemoradiation for Pancoast tumours †.
G. Marulli, L. Battistella, E. Perissinotto, C. Breda +6 more
2015Interactive Cardiovascular and Thoracic Surgery24 citations Open access
Semantic Scholar
Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).
J. Bennouna, L. Havel, M. Krzakowski, J. Kollmeier +17 more
2014Clinical Lung Cancer24 citations
Semantic Scholar
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer
M. di Maio, N. Leighl, C. Gallo, R. Feld +25 more
2012Journal of Thoracic Oncology24 citations Open access
Semantic Scholar
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
M. di Maio, S. Signoriello, A. Morabito, A. Rossi +22 more
2012Lung Cancer20 citations
Semantic Scholar
Effect of induction chemotherapy on lung function and exercise capacity in patients affected by malignant pleural mesothelioma.
G. Marulli, F. Rea, S. Nicotra, A. Favaretto +4 more
2010European Journal of Cardio-Thoracic Surgery20 citations Open access
Semantic Scholar
NCIC CTG BR.26: A phase III randomized, double blind, placebo controlled trial of dacomitinib versus placebo in patients with advanced/metastatic non-small cell lung cancer (NSCLC) who received prior chemotherapy and an EGFR TKI.
P. Ellis, Geoffrey Liu, M. Millward, F. Perrone +16 more
201419 citations
Semantic Scholar
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data
G. Pasello, L. Urso, M. Mencoboni, F. Grosso +10 more
2015OncoTarget18 citations Open access
Semantic Scholar
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
S. Frega, M. Lorenzi, M. Fassan, S. Indraccolo +12 more
2017OncoTarget17 citations Open access
Semantic Scholar
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization
V. Polo, G. Pasello, S. Frega, A. Favaretto +3 more
2016OncoTarget17 citations Open access
Semantic Scholar
Nondisruptive p 53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non – Small Cell Lung Cancer
M. Molina-Vila, J. Bertran-Alamillo, A. Gasc, C. Mayo-de-las-Casas +11 more
201417 citations
Semantic Scholar
Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.
C. Buttigliero, F. Shepherd, F. Barlesi, B. Schwartz +11 more
2018The Oncologist16 citations Open access
Semantic Scholar
Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
G. Marulli, Enrico Verderi, A. Zuin, M. Schiavon +6 more
2013Interactive Cardiovascular and Thoracic Surgery14 citations Open access
Semantic Scholar
Second-line Treatment of Advanced Non-small Cell Lung Cancer Non-oncogene Addicted: New Treatment Algorithm in the Era of Novel Immunotherapy.
C. Gridelli, P. Ascierto, F. Grossi, E. Baldini +6 more
2018Current Clinical Pharmacology12 citations
Semantic Scholar
Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature
V. Polo, G. Zago, S. Frega, F. Canova +6 more
2015The American journal of case reports12 citations Open access
Semantic Scholar
Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
G. Pasello, S. Nicotra, G. Marulli, F. Rea +5 more
2011Lung Cancer12 citations
Semantic Scholar
Synergistic Antitumor Activity of Recombinant Human Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Combination with Carboplatin and Pemetrexed in Malignant Pleural Mesothelioma
G. Pasello, L. Urso, M. Silic-Benussi, M. Schiavon +6 more
2014Journal of Thoracic Oncology11 citations Open access
Semantic Scholar
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial.
A. Morabito, G. Daniele, R. Costanzo, A. Favaretto +16 more
2017Lung Cancer10 citations
Semantic Scholar
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study
V. Guarneri, F. Bassan, V. Zagonel, M. Milella +25 more
2021European Journal of Cancer9 citations Open access
Semantic Scholar
Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
L. Bonanno, F. Calabrese, G. Nardo, D. Calistri +9 more
2016Lung Cancer9 citations
Semantic Scholar
Phase III trial (NGR015) with NGR-hTNF plus best investigator choice (BIC) versus placebo plus BIC in previously treated patients with advanced malignant pleural mesothelioma (MPM).
R. Gaafar, A. Favaretto, V. Gregorc, F. Grossi +14 more
20159 citations
Semantic Scholar
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study
C. Gridelli, F. de Marinis, A. Ardizzoni, S. Novello +13 more
2014Journal of Cancer Research and Clinical Oncology8 citations Open access
Semantic Scholar
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).
G. Pasello, G. Vicario, F. Zustovich, F. Oniga +22 more
2019The Oncologist7 citations Open access
Semantic Scholar
Phase I-II Trial of Gemcitabine-Based First-Line Chemotherapies for Small Cell Lung Cancer in Elderly Patients with Performance Status 0-2: The G-Step Trial
C. Gridelli, C. Gallo, A. Morabito, R. V. Iaffaioli +16 more
2012Journal of Thoracic Oncology7 citations Open access
Semantic Scholar
Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).
G. Pasello, G. Marulli, V. Polo, C. Breda +4 more
2012Anticancer Research7 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Bonanno×17
Invite
L. Bonanno — researcher profile on SciRah
G. Pasello×14
Invite
G. Pasello — researcher profile on SciRah
C. Gridelli×11
Invite
C. Gridelli — researcher profile on SciRah
F. Rea×11
Invite
F. Rea — researcher profile on SciRah

×10

Invite

A. Morabito — researcher profile on SciRah

Invite

P. Conte — researcher profile on SciRah

Invite

F. Perrone — researcher profile on SciRah

Invite

M. di Maio — researcher profile on SciRah

Invite

C. Gallo — researcher profile on SciRah

F. Calabrese×7

Invite

F. Calabrese — researcher profile on SciRah

Invite

A. Rossi — researcher profile on SciRah

Invite

G. Marulli — researcher profile on SciRah